1. Home
  2. RLMD vs GTIM Comparison

RLMD vs GTIM Comparison

Compare RLMD & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • GTIM
  • Stock Information
  • Founded
  • RLMD 2004
  • GTIM 1987
  • Country
  • RLMD United States
  • GTIM United States
  • Employees
  • RLMD N/A
  • GTIM N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • GTIM Restaurants
  • Sector
  • RLMD Health Care
  • GTIM Consumer Discretionary
  • Exchange
  • RLMD Nasdaq
  • GTIM Nasdaq
  • Market Cap
  • RLMD 20.3M
  • GTIM 17.1M
  • IPO Year
  • RLMD N/A
  • GTIM 1990
  • Fundamental
  • Price
  • RLMD $0.63
  • GTIM $1.73
  • Analyst Decision
  • RLMD Buy
  • GTIM
  • Analyst Count
  • RLMD 3
  • GTIM 0
  • Target Price
  • RLMD $5.00
  • GTIM N/A
  • AVG Volume (30 Days)
  • RLMD 142.9K
  • GTIM 34.9K
  • Earning Date
  • RLMD 08-07-2025
  • GTIM 08-07-2025
  • Dividend Yield
  • RLMD N/A
  • GTIM N/A
  • EPS Growth
  • RLMD N/A
  • GTIM 17.03
  • EPS
  • RLMD N/A
  • GTIM 0.12
  • Revenue
  • RLMD N/A
  • GTIM $143,398,000.00
  • Revenue This Year
  • RLMD N/A
  • GTIM N/A
  • Revenue Next Year
  • RLMD N/A
  • GTIM N/A
  • P/E Ratio
  • RLMD N/A
  • GTIM $14.67
  • Revenue Growth
  • RLMD N/A
  • GTIM 1.78
  • 52 Week Low
  • RLMD $0.24
  • GTIM $1.34
  • 52 Week High
  • RLMD $3.98
  • GTIM $3.45
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 51.70
  • GTIM 59.37
  • Support Level
  • RLMD $0.59
  • GTIM $1.69
  • Resistance Level
  • RLMD $0.64
  • GTIM $1.84
  • Average True Range (ATR)
  • RLMD 0.05
  • GTIM 0.10
  • MACD
  • RLMD 0.00
  • GTIM 0.03
  • Stochastic Oscillator
  • RLMD 55.00
  • GTIM 78.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.

Share on Social Networks: